Makers Of Opioids Are Asked For Data -- WSJ
By Thomas MacMillan
This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (September 20, 2017).
A bipartisan group of states investigating the opioid painkiller industry and the causes of widespread addiction has stepped up its probe with a fresh demand for documents from drugmakers and distributors.
States including New York, California and Tennessee announced the moves, saying a group of 41 attorneys general served subpoenas on manufacturers Endo International PLC, Janssen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Allergan PLC, and Purdue Pharma.
They also demanded documents from the three companies that account for about 90% of the country's opioid distribution: AmerisourceBergen Corp., Cardinal Health, and McKesson Corp.
"For millions of Americans, their personal battle with opioid addiction did not start in a back alley with a tourniquet and syringe," New York Attorney General Eric Schneiderman said at a press conference. "They got hooked on medicine they were prescribed for pain or that they found in a medicine cabinet."
The investigation marks the latest step in an investigation publicly announced by attorneys general this summer.
States including Ohio and Mississippi have gone further, filing lawsuits against pharmaceutical companies, alleging they misrepresented the addictive risks of their painkillers.
Representatives for Allergan, Teva, Janssen, Purdue, AmerisourceBergen, McKesson, and Cardinal Health said that they were cooperating with the investigation.